CASE REPORT
Published on 24 Sep 2026
Gefitinib-based therapy in refractory hepatocellular carcinoma with EGFR overexpression: a spatial profiling-guided case report
doi 10.3389/fimmu.2026.1891806
- 520 views
Articles
ORIGINAL RESEARCH
Published on 22 Sep 2026
A novel clinical FIT model predicts prognosis of unresectable hepatocellular carcinoma treated with TACE combined with lenvatinib and PD-1 inhibitors therapy
doi 10.3389/fimmu.2026.1906593
- 668 views
ORIGINAL RESEARCH
Published on 11 Jun 2026
Immune - cell death index in hepatocellular carcinoma: a multi-omics and machine learning study for prognosis and immunotherapy prediction
doi 10.3389/fimmu.2026.1776723
- 1,601 views
ORIGINAL RESEARCH
Published on 01 May 2026
Treatment for intermediate and advanced-stage hepatocellular carcinoma: does systemic therapy synergize the therapeutic efficacy of TACE?
doi 10.3389/fimmu.2026.1819885
- 1,643 views
- 2 citations
